New Releases from NCBI BookshelfPembrolizumab with gemcitabine and cisplatin for untreated advanced biliary tract cancer (terminated appraisal).​Pembrolizumab with gemcitabine and cisplatin for untreated advanced biliary tract cancer (terminated appraisal).